Issue 2/2017
Content (21 Articles)
Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
Rowan T. Chlebowski, Kathy Pan, Nananda F. Col
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan
Muhammad U. Rashid, Noor Muhammad, Asim Amin, Asif Loya, Ute Hamann
Using machine learning to parse breast pathology reports
Adam Yala, Regina Barzilay, Laura Salama, Molly Griffin, Grace Sollender, Aditya Bardia, Constance Lehman, Julliette M. Buckley, Suzanne B. Coopey, Fernanda Polubriaginof, Judy E. Garber, Barbara L. Smith, Michele A. Gadd, Michelle C. Specht, Thomas M. Gudewicz, Anthony J. Guidi, Alphonse Taghian, Kevin S. Hughes
The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer
Keely May McNamara, Saki Oguro, Fumiya Omata, Kyoko Kikuchi, Fouzia Guestini, Koyu Suzuki, Yang Yang, Eriko Abe, Hisashi Hirakawa, Kristy A. Brown, Ishida Takanori, Noriaki Ohuchi, Hironobu Sasano
Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals
J. Huang, P. Woods, D. Normolle, J. P. Goff, P. V. Benos, C. J. Stehle, R. A. Steinman
Clinical outcomes linked to expression of gene subsets for protein hormones and their cognate receptors from LCM-procured breast carcinoma cells
Michael W. Daniels, Guy N. Brock, James L. Wittliff
Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis
Ruo-Xi Wang, Sheng Chen, Xi Jin, Can-Ming Chen, Zhi-Ming Shao
Endocan as a prognostic biomarker of triple-negative breast cancer
Atsunobu Sagara, Katsuhide Igarashi, Maky Otsuka, Akihiro Kodama, Mutsumi Yamashita, Rei Sugiura, Takeshi Karasawa, Kazuhiko Arakawa, Michiko Narita, Naoko Kuzumaki, Minoru Narita, Yoshinori Kato
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Xiaoxian Li, Jing Yang, Limin Peng, Aysegul A. Sahin, Lei Huo, Kevin C. Ward, Ruth O’Regan, Mylin A. Torres, Jane L. Meisel
Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience
Mike G. Bourke, Slav P. Salwa, Mira Sadadcharam, Maria C. Whelan, Patrick F. Forde, John O. Larkin, Chris G. Collins, Seamus O’Reilly, Gerald C. O’Sullivan, A. James Clover, Declan M. Soden
Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial
Suzanna Maria Zick, Justin Colacino, Maria Cornellier, Tohfa Khabir, Katie Surnow, Zora Djuric
Up to one-third of breast cancer cases in post-menopausal Mediterranean women might be avoided by modifying lifestyle habits: the EPIC Italy study
Giovanna Masala, Benedetta Bendinelli, Melania Assedi, Daniela Occhini, Ines Zanna, Sabina Sieri, Claudia Agnoli, Carlotta Sacerdote, Fulvio Ricceri, Amalia Mattiello, Salvatore Panico, Rosario Tumino, Graziella Frasca, Calogero Saieva, Domenico Palli
Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study
Avonne E. Connor, Kala Visvanathan, Kathy B. Baumgartner, Richard N. Baumgartner, Stephanie D. Boone, Lisa M. Hines, Roger K. Wolff, Esther M. John, Martha L. Slattery
Previous GWAS hits in relation to young-onset breast cancer
Min Shi, Katie M. O’Brien, Dale P. Sandler, Jack A. Taylor, Dmitri V. Zaykin, Clarice R. Weinberg
Trends in cardiac mortality in women with ductal carcinoma in situ
Waqar Haque, Vivek Verma, Anam Haque, E. Brian Butler, Bin S. Teh
Differences in mammographic density between Asian and Caucasian populations: a comparative analysis
Nadia Rajaram, Shivaani Mariapun, Mikael Eriksson, Jose Tapia, Pui Yoke Kwan, Weang Kee Ho, Faizah Harun, Kartini Rahmat, Kamila Czene, Nur Aishah Mohd Taib, Per Hall, Soo Hwang Teo
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)
Rachel A. Freedman, D. K. Seisler, J. C. Foster, J. A. Sloan, J. M. Lafky, G. G. Kimmick, A. Hurria, H. J. Cohen, E. P. Winer, C. A. Hudis, A. H. Partridge, L. A. Carey, A. Jatoi, H. D. Klepin, M. Citron, D. A. Berry, L. N. Shulman, A. U. Buzdar, V. J. Suman, H. B. Muss
Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample
Jennifer J. Griggs, Ann S. Hamilton, Kendra L. Schwartz, Weiqiang Zhao, Paul H. Abrahamse, Dafydd G. Thomas, Julie M. Jorns, Rachel Jewell, Maria E. Sibug Saber, Reina Haque, Steven J. Katz
Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
Lotte E. Elshof, Michael Schaapveld, Marjanka K. Schmidt, Emiel J. Rutgers, Flora E. van Leeuwen, Jelle Wesseling